Prediagnostic Image Data, Artificial Intelligence, and Pancreatic Cancer: A Tell-Tale Sign to Early Detection.


Journal

Pancreas
ISSN: 1536-4828
Titre abrégé: Pancreas
Pays: United States
ID NLM: 8608542

Informations de publication

Date de publication:
08 2020
Historique:
entrez: 18 7 2020
pubmed: 18 7 2020
medline: 3 8 2021
Statut: ppublish

Résumé

Pancreatic cancer continues to be one of the deadliest malignancies and is the third leading cause of cancer-related mortality in the United States. Based on several models, it is projected to become the second leading cause of cancer-related deaths by 2030. Although the overall survival rate for patients diagnosed with pancreatic cancer is less than 10%, survival rates are increasing in those whose cancers are detected at an early stage, when intervention is possible. There are, however, no reliable biomarkers or imaging technology that can detect early-stage pancreatic cancer or accurately identify precursors that are likely to progress to malignancy. The Alliance of Pancreatic Cancer Consortia, a virtual consortium of researchers, clinicians, and advocacies focused on early diagnosis of pancreatic cancer, was formed in 2016 to provide a platform and resources to discover and validate biomarkers and imaging methods for early detection. The focus of discussion at the most recent alliance meeting was on imaging methods and the use of artificial intelligence for early detection of pancreatic cancer.

Identifiants

pubmed: 32675784
doi: 10.1097/MPA.0000000000001603
pii: 00006676-202008000-00002
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

882-886

Références

Henley SJ, Ward EM, Scott S, et al. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer. 2020;126:2225–2249.
American Cancer Society. Cancer Facts & Figures 2020. Available at: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf. Accessed April 26, 2020.
Hruban RH. Is the early detection of pancreatic cancer possible? It is good news, bad news. Pancreas. 2019;48:591–593.
Young MR, Wagner PD, Ghosh S, et al. Validation of biomarkers for early detection of pancreatic cancer: summary of the Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection workshop. Pancreas. 2018;47:135–141.
National Cancer Institute. Scientific framework for pancreatic ductal adenocarcinoma (PDAC). February 2014. Available at https://deainfo.nci.nih.gov/advisory/ctac/workgroup/pc/pdacframework.pdf. Accessed April 26, 2020.
Abbruzzese J. Progress in pancreatic ductal adenocarcinoma (PDAC) research working group update. November 7, 2018. Available at https://deainfo.nci.nih.gov/advisory/ctac/1118/Abbruzzese12.pdf. Accessed April 26, 2020.
National Cancer Institute Clinical Trials and Translational Research Advisory Committee. Working Group Report. March 6, 2019. Available at https://deainfo.nci.nih.gov/advisory/ctac/workgroup/PDAC/WGreport2019.pdf. Accessed April 26, 2020.
Park S, Chu LC, Fishman EK, et al. Annotated normal CT data of the abdomen for deep learning: challenges and strategies for implementation. Diagn Interv Imaging. 2020;101:35–44.
Chu LC, Johnson PT, Fishman EK. Cinematic rendering of pancreatic neoplasms: preliminary observations and opportunities. Abdom Radiol (NY). 2018;43:3009–3015.
Chu LC, Park S, Kawamoto S, et al. Utility of CT radiomics features in differentiation of pancreatic ductal adenocarcinoma from normal pancreatic tissue. AJR Am J Roentgenol. 2019;213:349–357.
Chu LC, Park S, Kawamoto S, et al. Application of deep learning to pancreatic cancer detection: lessons learned from our initial experience. J Am Coll Radiol. 2019;16:1338–1342.
Nam JG, Park S, Hwang EJ, et al. Development and validation of deep learning-based automatic detection algorithm for malignant pulmonary nodules on chest radiographs. Radiology. 2019;290:218–228.
Yala A, Lehman C, Schuster T, et al. A deep learning mammography-based model for improved breast cancer risk prediction. Radiology. 2019;292:60–66.
Baecker A, Kim S, Risch HA, et al. Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data. PLoS One. 2019;14:e0218580.
Prior F, Almeida J, Kathiravelu P, et al. Open access image repositories: high-quality data to enable machine learning research. Clin Radiol. 2020;75:7–12.
Schaffter T, Buist DSM, Lee CI, et al. Evaluation of combined artificial intelligence and radiologist assessment to interpret screening mammograms. JAMA Netw Open. 2020;3:e200265.
Chang K, Balachandar N, Lam C, et al. Distributed deep learning networks among institutions for medical imaging. J Am Med Inform Assoc. 2018;25:945–954.
Deist TM, Jochems A, van Soest J, et al. Infrastructure and distributed learning methodology for privacy-preserving multi-centric rapid learning health care: euroCAT. Clin Transl Radiat Oncol. 2017;4:24–31.
Ellrott K, Buchanan A, Creason A, et al. Reproducible biomedical benchmarking in the cloud: lessons from crowd-sourced data challenges. Genome Biol. 2019;20:195.
Guinney J, Saez-Rodriguez J. Alternative models for sharing confidential biomedical data. Nat Biotechnol. 2018;36:391–392.
Deist TM, Dankers FJWM, Ojha P, et al. Distributed learning on 20 000+ lung cancer patients—the personal health train. Radiother Oncol. 2020;144:189–200.
Sheller MJ, Reina GA, Edwards B, et al. Multi-institutional deep learning modeling without sharing patient data: a feasibility study on brain tumor segmentation. Brainlesion. 2019;11383:92–104.
Langlotz CP, Allen B, Erickson BJ, et al. A roadmap for foundational research on artificial intelligence in medical imaging: from the 2018 NIH/RSNA/ACR/the academy workshop. Radiology. 2019;291:781–791.
Hutson M. Artificial intelligence faces reproducibility crisis. Science. 2018;359:725–726.
Park JE, Park SY, Kim HJ, et al. Reproducibility and generalizability in radiomics modeling: possible strategies in radiologic and statistical perspectives. Korean J Radiol. 2019;20:1124–1137.
Houssami N, Kirkpatrick-Jones G, Noguchi N, et al. Artificial intelligence (AI) for the early detection of breast cancer: a scoping review to assess AI's potential in breast screening practice. Expert Rev Med Devices. 2019;16:351–362.

Auteurs

Matthew R Young (MR)

From the Cancer Biomarker Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH